Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyridoxal Kinase Activity in Schizophrenia Patients Without Versus With Tardive Dyskinesia Treated With Vitamin B6

NCT01908452 is registered in ClinicalTrials.gov with Beersheva Mental Health Center as lead sponsor.

NCT NCT01908452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01908452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyridoxal Kinase Activity in Schizophrenia Patients Without Versus With Tardive Dyskinesia Treated With Vitamin B6
Lead sponsor
Beersheva Mental Health Center
Phase
Phase 3
Overall status
Withdrawn
Start date
July 31, 2011
Completion date
July 31, 2011
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

tardive dyskinesia